NEU
Listed Company
Neuren Pharmaceuticals Limited (ASX NEU)
Followers
133
Exchange
ASX
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology & Life Sciences
Popular News mentioning ASX NEU
How to buy something for nothing on the ASX (2 strategies, 3 stock ideas)
Seneca Financial Solutions
Watch
Investing at the inflexion point in healthcare innovation
Livewire Markets
Advertisement
Latest News on Neuren Pharmaceuticals Limited
NEU
Neuren Pharmaceuticals Ltd
ASX:NEU
Followed by 133 people
SNT
Syntara Ltd
ASX:SNT
Followed by 17 people
Livewire Markets
AQN
Aquirian Ltd
ASX:AQN
Followed by 27 people
ASB
Austal Ltd
ASX:ASB
Followed by 444 people
BHP
BHP Group Ltd
ASX:BHP
Followed by 2222 people
Seneca Financial Solutions
ALX
Atlas Arteria
ASX:ALX
Followed by 367 people
BRG
Breville Group Ltd
ASX:BRG
Followed by 105 people
CTD
Corporate Travel Management Ltd
ASX:CTD
Followed by 153 people
.jpg)
Livewire Markets
AD8
Audinate Group Ltd
ASX:AD8
Followed by 997 people
ALD
Ampol Ltd
ASX:ALD
Followed by 549 people
APA
APA Group
ASX:APA
Followed by 1014 people
Livewire Markets
BOT
Botanix Pharmaceuticals Ltd
ASX:BOT
Followed by 86 people
CVB
Curvebeam Ai Ltd
ASX:CVB
Followed by 15 people
DXB
Dimerix Ltd
ASX:DXB
Followed by 52 people
KP Rx
Covering Neuren Pharmaceuticals Limited
Buy Hold Sell
Livewire Markets
James Gerrish
Market Matters
Hashan De Silva
KP Rx
Claire Aitchison
Independent Investment Research
Kerry Sun
Livewire Markets
Sara Allen
Livewire Markets
Neuren Pharmaceuticals Limited (ASX:NEU) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is NEU. Livewire Markets has 19 experts who have published 49 articles that have featured Neuren Pharmaceuticals Limited. You can view all those wires here. The last time time NEU was featured was on the 06 June 2025 by Chris Conway in the wire “Investing at the inflexion point in healthcare innovation”. Get the latest NEU share price and other key information like NEU Financials on Market Index.